Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors. Desai R, Smith SM, Mohandas R, Brown J, et al. Ann Pharmacother 2024;58:886-895.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Desai R, Smith SM, Mohandas R, Brown J, et al. Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors. Ann Pharmacother 2024;58:886-895.
PMID: 38078408